ANI Pharmaceuticals Inc Capital Reinvestment Ratio
ANI Pharmaceuticals Inc capital reinvestment ratio. ANI Pharmaceuticals Inc (ANIP) has a Capital Reinvestment Ratio of 0.79x as of December 2025, meaning it reinvests 1% of its operating cash flow ($30.37 Million) in capital expenditures ($23.86 Million). See ANI Pharmaceuticals Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of ANI Pharmaceuticals Inc (2007–2025)
Capital reinvestment ratio of ANI Pharmaceuticals Inc from 2007 to 2025. This chart tracks ANI Pharmaceuticals Inc's Capital Reinvestment Ratio across 12 annual periods. See how financially flexible is ANI Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
ANI Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2007–2025)
ANI Pharmaceuticals Inc capital reinvestment ratio by year from 2007 to 2025. For the full cash flow conversion analysis, see ANI Pharmaceuticals Inc operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | $185.22 Million | $13.84 Million | ▼ -71.8% |
| 2024 | 0.26x | $64.02 Million | $16.95 Million | ▲ +70.2% |
| 2023 | 0.16x | $118.96 Million | $18.51 Million | ▼ -97.8% |
| 2021 | 7.12x | $3.32 Million | $23.64 Million | ▲ +59.0% |
| 2020 | 4.48x | $15.27 Million | $68.32 Million | ▲ +641.2% |
| 2019 | 0.60x | $45.63 Million | $27.55 Million | ▲ +271.1% |
| 2018 | 0.16x | $67.07 Million | $10.91 Million | ▼ -94.1% |
| 2017 | 2.74x | $39.42 Million | $107.99 Million | ▼ -49.5% |
| 2016 | 5.43x | $27.47 Million | $149.06 Million | ▲ +186.6% |
| 2015 | 1.89x | $17.26 Million | $32.68 Million | ▲ +16.7% |
| 2014 | 1.62x | $22.03 Million | $35.75 Million | ▲ +3980.5% |
| 2007 | 0.04x | $739.99K | $29.43K | — |